| GRRPX | RNWAX | GRRPX / RNWAX | |
| Total Expense Ratio | 1.59 | 1.66 | 96% |
| Annual Report Gross Expense Ratio | 1.76 | 1.66 | 106% |
| Fund Existence | 12 years | 24 years | - |
| Gain YTD | 11.374 | 6.005 | 189% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.91B | 75.5B | 4% |
| Annual Yield % from dividends | 1.59 | 0.53 | 300% |
| Returns for 1 year | 46.63 | 26.30 | 177% |
| Returns for 3 years | 64.97 | 38.84 | 167% |
| Returns for 5 years | 6.43 | 7.02 | 92% |
| Returns for 10 years | 109.91 | 114.12 | 96% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CUSIX | 14.84 | 0.07 | +0.47% |
| Cullen Small Cap Value I | |||
| BIPIX | 71.69 | 0.25 | +0.35% |
| ProFunds Biotechnology UltraSector Inv | |||
| GDSRX | 27.65 | 0.05 | +0.18% |
| Goldman Sachs Small Cap Eq Insghts R | |||
| FSPHX | 28.66 | N/A | N/A |
| Fidelity Select Health Care | |||
| MSFAX | 27.99 | -0.92 | -3.18% |
| Morgan Stanley Inst Global Franchise I | |||